LMH STRATEGIC SOLUTIONS

Lobbying for STEALTH BIOTHERAPEUTICS INC. · Biotechnology company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $30,000.00 income · posted Jan 12, 2026

Bills named in this filing 2

Lobbying activity 1

Health Issues

FDA process issues. H.R.1262/S.932 - Give Kids a Chance Act of 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.